JOA - 2026-11-06 - Journal Article
Economic Evaluation of Dual Mobility Versus Conventional Liners in High-Risk Primary Total Hip Arthroplasty in a Single-Payer Universal Healthcare System.
Koucheki R, Abbaspour R, Abbas A, Lex JR, Tomescu S, Pincus D, Nousiainen M, Khoshbin A, Ravi B
Topics
Key Takeaway
Dual mobility liners in high-risk primary THA yield an ICER of CAD 18,053/QALY—well below the CAD 50,000 willingness-to-pay threshold—with economic break-even achieved by postoperative year two.
Summary Depth
Choose how much analysis to show on this article page.
Summary
This Markov cohort model compared dual mobility versus conventional liners in high-risk primary THA patients (prior lumbar fusion, spinopelvic imbalance, neuromuscular disease) from a Canadian single-payer perspective over 10 years. A 3.2× dislocation risk multiplier and a relative risk reduction of 0.40 for DM were applied; DM produced 68 fewer dislocations and 31 fewer revisions per 1,000 patients at a net incremental cost of CAD 566/patient. The ICER was CAD 18,053/QALY with 92.8% probability of cost-effectiveness at the CAD 50,000 threshold.
Key Limitation
The model relies on a single pooled high-risk category; dislocation probabilities and cost-effectiveness likely differ substantially across the constituent subgroups (lumbar fusion vs. neuromuscular disease vs. spinopelvic imbalance), which the analysis cannot distinguish.
Original Abstract
BACKGROUND
Dislocation is one of the leading causes of revision after total hip arthroplasty (THA), and its burden is substantially greater in patients who have prior lumbar fusion, spino-pelvic imbalance, or neuromuscular disease. This study aimed to assess the cost-effectiveness of dual mobility (DM) liners compared with conventional bearings in high-risk primary THA from a single-payer hospital perspective.
METHODS
A Markov cohort model with annual cycles was developed with four health states: well post-surgery, dislocation, revision, and death. The model considered a hypothetical cohort of 1,000 patients at elevated instability risk over a 10-year horizon. A high-risk multiplier of 3.2 was applied to baseline dislocation probabilities, and DM was modeled with a relative risk of dislocation of 0.40. Costs were expressed in 2024 Canadian dollars and discounted at 1.5% annually. Outcomes included total costs, quality-adjusted life-years (QALYs), incremental cost-effectiveness ratio (ICER), and net monetary benefit (NMB). We used one-way, threshold, and probabilistic sensitivity analyses.
RESULTS
The DM liners resulted in 68 fewer dislocations and 31 fewer revisions per 1,000 patients over 10 years (number needed to treat 15 to prevent one dislocation and 33 to prevent one revision), at a net incremental cost of CAD 566 per patient. The ICER was CAD 18,053 per QALY gained, well below the CAD 50,000 threshold. Economic break-even was achieved by the second postoperative year. At the CAD 50,000 threshold, the probability of cost-effectiveness was 92.8%.
CONCLUSIONS
In patients at elevated risk of instability following primary THA, dual mobility liners are cost-effective from the perspective of a publicly funded healthcare system, with break-even achieved within two years of surgery. These findings support the selective use of DM as the construct of first choice in this population rather than a response to failure.